William P. Forbes
Executive VP & Chief Development OfficerDr. William P. Forbes, also known as Bill, Pharm. D., serves as Executive Vice President & Chief Development Officer at Heron Therapeutics Inc. since June 6, 2023. He serves as Director at Hallux Inc. He served as Chief Development Officer at Trevi Therapeutics Inc. since February 2021 until September 01, 2022. He has been Independent Director of Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.) since August 13, 2018. From March 2016 to June 2020, he served as Founder, President and CEO of Vivelix Pharmaceuticals, a specialty pharmaceutical company. Dr. Forbes has been the President and Chief Executive Officer of Vivelix Pharmaceuticals, Ltd., a clinical-stage pharmaceutical company, founded by Dr. Forbes that focuses on gastrointestinal diseases. He served as the Chief Development Officer of Salix Pharmaceuticals, Inc and also Head of Medical and R&D from January 2005 to June 2015 and served as its President of Medical, Research & Development. Before joining Trevi, Dr. Forbes was an Independent Consultant in the pharmaceutical industry from June 2020 to February 2021. Dr. Forbes served as President of Medical, Research & Development at Salix Pharmaceuticals, Inc, since February 2015. Dr. Forbes served as Chief Medical Officer of Salix Pharmaceuticals, Inc since January 2005 and its Executive Vice President of Research and Development from 2010 to February 2015. Dr. Forbes served as Senior Vice President of Research and Development of Salix Pharmaceuticals, Inc. Dr. Forbes served as a Vice President of Research and Development at Salix Pharmaceuticals, Inc since January 2005. He served as Vice President of Clinical Development and Regulatory Affairs of Metabasis Therapeutics Inc. from August 2002 to 2004. He served as a Group Leader at Otsuka America Pharmaceutical, Inc. since 1996 and held various senior management positions in clinical research at Otsuka from 1991 to 2002. Dr. Forbes served as Senior Clinical Research Scientist at Glaxo Inc. from 1989 to 1991. He has broad base of knowledge and experience in the areas of clinical development, regulatory affairs and project management gained over career in the pharmaceutical industry. Dr. Forbes holds a Pharmacy degree from Creighton University and conducted post-doctoral works at the Creighton Cardiac Center and the Cardiovascular Clinical Research department at Glaxo. Before joining Otsuka, Dr. Forbes served as Senior Clinical Research Scientist at Glaxo, Inc. Dr. Forbes received a PharmD from Creighton University and conducted postdoctoral work at the Creighton Cardiac Center and the Cardiovascular Clinical Research department at Glaxo.
Positions
- Company NameHeron Therapeutics, Inc.Stock CodeHRTXPositionExecutive VP & Chief Development OfficerColleagues
